CMN Intelligence
The world’s most comprehensive intelligence platform for CRISPR-Genomic Medicine and gene-editing clinical development.
Providing market intelligence, data infrastructure, analytics, and reporting services for the global gene-editing sector.
CMN Global Clinical Trials Report 2026 (>250 trials)
Available February 2026. Request more info here.
The CMN Global Clinical Trials Report 2026 includes comprehensive and up-to-date clinical trial data from the CMN Global Clinical Trials Database 2.0, covering approximately 300 clinical trials worldwide. The first global edition of the report will be available in February 2026. This report and any figures or extracts derived from it are intended for internal use only and may not be shared outside your company or organisation. All content and figures are copyright protected.
This report includes among others detailed insights on:
Disease/Indication
Trial Locations (by country)
Phase
Editing Approach
Type of Edit
Editing Modality
Delivery Vehicle for Gene-Editing Reagents
Delivery Vehicle for Repair Template
Delivery Format for Gene-Editing Reagents
Delivery Format for Repair Template
Route of Administration
...
Request further details regarding license availability for 2026.
Meet the global CRISPR Medicine community in Copenhagen, April 13-16, at CRISPRMED26.
-----------------
Terms of Use & License Agreement | Cookie Policy | Privacy Policy
